FDA Approves Lucentis Treatment for Diabetic Retinopathy

Article

The FDA today expanded the indication of Roche's ranibizumab (Lucentis), approving the drug for the treatment of diabetic retinopathy in patients with diabetic macular edema.

The FDA today expanded the indication of Roche’s ranibizumab (Lucentis), approving the drug for the treatment of diabetic retinopathy (DR) in patients with diabetic macular edema (DME).

Lucentis, a vascular endothelial growth factor (VEGF), was previously approved to treat DME and macular edema secondary to retinal vein occlusions, as well as wet (neovascular) age-related macular degeneration. A supplemental New Drug Application to include the treatment of DR in the drug’s approved uses was granted priority review by the FDA in October 2014.

The FDA based its nod on positive results from 2 clinical studies evaluating the safety and efficacy of Lucentis in 759 patients with DR. Compared with patients who did not receive treatment, Lucentis-treated participants reported significant improvement in their DR’s severity after 2 years.

“Diabetes is a serious public health crisis, affecting more patients every year,” said Edward Cox, MD, MPH, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research, in a press release. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema the first significant therapy to treat this vision-impairing complication.”

The most common adverse events reported by trial participants treated with Lucentis include bleeding of the conjunctiva, eye pain, floaters, and increased intraocular pressure inside the eye. Several Lucentis-treated patients experienced more serious side effects such as endophthalmitis and retinal detachments.

DR, a leading cause of blindness in adults in the United States, is the most common eye disease associated with diabetes.

Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.